AAAAAA

   
Results: 1-8 |
Results: 8
Chiral synthesis and pharmacological evaluation of NPS 1407: A potent, stereoselective NMDA receptor antagonist
Authors: Moe, ST Smith, DL DelMar, EG Shimizu, SM Van Wagenen, BC Balandrin, MF Chien, YW Raszkiewicz, JL Artman, LD White, HS Mueller, AL
Citation: St. Moe et al., Chiral synthesis and pharmacological evaluation of NPS 1407: A potent, stereoselective NMDA receptor antagonist, BIOORG MED, 10(21), 2000, pp. 2411-2415
NPS 1506, a moderate affinity uncompetitive NMDA receptor antagonist: preclinical summary and clinical experience
Authors: Mueller, AL Artman, LD Balandrin, MF Brady, E Chien, Y DelMar, EG Kierstead, A Marriott, TB Moe, ST Raszkiewicz, JL VanWagenen, B Wells, D
Citation: Al. Mueller et al., NPS 1506, a moderate affinity uncompetitive NMDA receptor antagonist: preclinical summary and clinical experience, AMINO ACIDS, 19(1), 2000, pp. 177-179
NPS 1506: A novel NMDA receptor antagonist - Neuroprotective effects in a model of closed head trauma in rats
Authors: Lorber, A Artru, AA Lam, AM Mueller, AL Karpas, Z Roytblat, L Shapira, S
Citation: A. Lorber et al., NPS 1506: A novel NMDA receptor antagonist - Neuroprotective effects in a model of closed head trauma in rats, J NEUROS AN, 12(4), 2000, pp. 345-355
Long-term potentiation in the presence of NMDA receptor antagonist arylalkylamine spider toxins
Authors: Albensi, BC Alasti, N Mueller, AL
Citation: Bc. Albensi et al., Long-term potentiation in the presence of NMDA receptor antagonist arylalkylamine spider toxins, J NEUROSC R, 62(2), 2000, pp. 177-185
NPS 1506 attenuates cognitive dysfunction and hippocampal neuron death following brain trauma in the rat
Authors: Leoni, MJ Chen, XH Mueller, AL Cheney, J McIntosh, TK Smith, DH
Citation: Mj. Leoni et al., NPS 1506 attenuates cognitive dysfunction and hippocampal neuron death following brain trauma in the rat, EXP NEUROL, 166(2), 2000, pp. 442-449
Synthesis, biological activity, and absolute stereochemical assignment of NPS 1392: A potent and stereoselective NMDA receptor antagonist
Authors: Moe, ST Shimizu, SM Smith, DL Van Wagenen, BC DelMar, EG Balandrin, MF Chien, YW Raszkiewicz, JL Artman, LD Mueller, AL Lobkovsky, E Clardy, J
Citation: St. Moe et al., Synthesis, biological activity, and absolute stereochemical assignment of NPS 1392: A potent and stereoselective NMDA receptor antagonist, BIOORG MED, 9(14), 1999, pp. 1915-1920
Peptide toxins isolated from spider venom that modulate gating of voltage-dependent K+ channels
Authors: Garrett, SA Mueller, AL Sanguinetti, MC
Citation: Sa. Garrett et al., Peptide toxins isolated from spider venom that modulate gating of voltage-dependent K+ channels, PERSP DR D, 16, 1999, pp. 71-81
Recommendations for standards regarding preclinical neuroprotective and restorative drug development
Authors: Feinklestein, SP Fisher, M Furland, AJ Goldstein, LB Gorelick, PB Kaste, M Lees, KR Traystman, RJ Albers, GW Anwer, UE Ashwood, T Barone, FC Basta, SL Bogousslavsky, J Buchan, AM Cady, WJ Chan, PH Clemens, JA Cox, BF Craddock, RE Cramer, SC del Zoppo, GJ Dielrich, WD Elliott, P Faden, AI Feuerstein, GZ Ginsberg, MD Gold, M Greene, WL Hall, ED Hsu, CY Hunter, AJ Lai, M Lesko, LM Levy, DE Li, FH Locke, KW Lodge, D Lowe, D Marcoux, FW McCulloch, J McDermott, J Meibach, R Messersmith, EK Moseley, M Moskowitz, MA Mueller, AL Munro, F Nudo, RJ Oeda, J Ohlstein, EH Parsons, A Patmore, L Poole, RM Pschorn, U Pulsinelli, WA Sacco, RL Saeki, S Salazar-Grueso, E Sandage, BW Schallert, T Schielke, GP Sharkey, J Sotak, CH Steiger, B Storall, S Takahashi, Y Tumas, D Van Bruggen, N Versavel, M Vornov, J Walker, MD Wallin, B Wang, J Warach, S Wells, DS Witcher, JA
Citation: Sp. Feinklestein et al., Recommendations for standards regarding preclinical neuroprotective and restorative drug development, STROKE, 30(12), 1999, pp. 2752-2758
Risultati: 1-8 |